Who is sponsoring NCT03049059?

NCT03049059 is sponsored by Mae Fah Luang University Hospital.

What drugs are being tested in NCT03049059?

Interventions in NCT03049059: Fractional Picosecond 1,064 nm laser, 4% hydroquinone cream.

What condition does NCT03049059 study?

NCT03049059 studies Picoseconds Laser, Melasma.

Is NCT03049059 still recruiting?

NCT03049059 is currently completed. Last updated 9 February 2017.

Last reviewed 2017-02-09 · How we verify

NCT03049059

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Comparative Study for Efficacy and Safety Between 4% Hydroquinone Cream With or Without Fractional Picosecond 1,064 nm Laser for the Treatment of Dermal or Mixed Type Melasma

Completed Phase 2 Last updated 9 February 2017

What this trial tests

Phase 2 trial testing Fractional Picosecond 1,064 nm laser in Picoseconds Laser in 30 participants. Completed in 1 February 2017.

Timeline

1 June 2016

Primary endpoint
1 December 2016

1 February 2017

Quick facts

Lead sponsor	Mae Fah Luang University Hospital
Phase	Phase 2
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	30
Start date	1 June 2016
Primary completion	1 December 2016
Estimated completion	1 February 2017

Drugs / interventions tested

Fractional Picosecond 1,064 nm laser
4% hydroquinone cream — full drug profile →

Conditions studied

Picoseconds Laser — all drugs for Picoseconds Laser →
Melasma — all drugs for Melasma →

Sponsor

Mae Fah Luang University Hospital

Who can join

Adults 18 to 65, female only, with Picoseconds Laser or Melasma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A Comparative study for Efficacy and Safety Between 4% hydroquinone cream with or without Fractional Picosecond 1,064 nm Laser for the Treatment of Dermal or Mixed Type Melasma

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Mae Fah Luang University Hospital trials

Trials by the same sponsor.

NCT03054480 — Fractional Micro-Needle Radiofrequency and I Botulinum Toxin A for Primary Axillary Hyperhidrosis · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03049059 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mae Fah Luang University Hospital
Last refreshed: 9 February 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03049059.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing